Understanding Unique Features of Human Adenosine Deaminases Acting on RNA PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Understanding Unique Features of Human Adenosine Deaminases Acting on RNA PDF full book. Access full book title Understanding Unique Features of Human Adenosine Deaminases Acting on RNA by SeHee Park. Download full books in PDF and EPUB format.
Author: SeHee Park Publisher: ISBN: Category : Languages : en Pages : 0
Book Description
Adenosine Deaminases that act on RNA (ADARs) are a family of enzymes that convert adenosine to inosine in dsRNA which is a common form of RNA editing. Because inosine is recognized as guanosine by cellular machinery, there are numerous consequences resulting from ADAR mediated A-to-I editing including protein recoding event. Therefore, proper ADAR activity is necessary for several cellular processes. In fact, it has been shown that aberrant activities of ADARs can lead to various human diseases such as cancer and neurological disorders. It is especially important to understand ADAR1's biological function and activity because ADAR1 plays an essential role in innate immunity and it is a potential therapeutic target for a subset of cancers based on several recent studies. Although our understanding of ADARs has been significantly improved over a few decades, there are still important questions that need to be answered, especially regarding ADAR1 activity and its interaction with RNA substrates to better understand its biological roles in humans. This dissertation describes the exploration of unique features of human ADARs that could affect their catalytic activity as well as substrate recognition through several biochemical experiments and the attempts for structural characterization of ADARs. In chapter 1, an overview of RNA editing and its consequences are described with respect to A-to-I editing mediated by ADARs, highlighting its catalytic activity, substrate selectivity, and biological consequences that are linked to various human diseases. More details on the biological role of ADAR1 in humans are included to further emphasize the importance of understanding ADAR1 biology. Chapter 2 describes the high-throughput functional screening of the 5' binding loop of ADAR1. The 5' binding loop of ADARs plays an important role in RNA recognition. Yet, its sequence is substantially different among ADARs. Therefore, this work helps us better understand the selectivity difference between ADAR1 and ADAR2. Chapter 3 is focused on the exploration of covalent crosslinking, which takes advantage of a disulfide bond formation between the Cys mutant of ADARs and thiol modified dsRNA to stabilize various ADAR-dsRNA complexes for biophysical characterization. Various novel thiol modified nucleoside analogs are utilized to optimize covalent crosslinking of ADARs and the results suggest this strategy has the potential to advance our knowledge of ADARs through structural studies. Chapter 4 describes the discovery of a second metal binding site that is unique to ADAR1 and important for its catalytic activity along with the computational modeling of the ADAR1 deaminase domain structure using this novel feature of ADAR1. These collaborative works provide more insight into the unique properties of ADAR1. In Chapter 5, the optimization of ADAR1 catalytic domain purification is described in detail that leads to several crystallization trials for biophysical characterization of the ADAR1 deaminase domain through X-ray crystallography. Moreover, results from a binding study with a duplex RNA containing an adenosine analog, 8-azanebularine, further provide an additional approach to stabilize the ADAR1-dsRNA complex for X-ray crystallography. Lastly, inhibition of ADARs activity was investigated using various small molecules, which is discussed in Chapter 6.
Author: SeHee Park Publisher: ISBN: Category : Languages : en Pages : 0
Book Description
Adenosine Deaminases that act on RNA (ADARs) are a family of enzymes that convert adenosine to inosine in dsRNA which is a common form of RNA editing. Because inosine is recognized as guanosine by cellular machinery, there are numerous consequences resulting from ADAR mediated A-to-I editing including protein recoding event. Therefore, proper ADAR activity is necessary for several cellular processes. In fact, it has been shown that aberrant activities of ADARs can lead to various human diseases such as cancer and neurological disorders. It is especially important to understand ADAR1's biological function and activity because ADAR1 plays an essential role in innate immunity and it is a potential therapeutic target for a subset of cancers based on several recent studies. Although our understanding of ADARs has been significantly improved over a few decades, there are still important questions that need to be answered, especially regarding ADAR1 activity and its interaction with RNA substrates to better understand its biological roles in humans. This dissertation describes the exploration of unique features of human ADARs that could affect their catalytic activity as well as substrate recognition through several biochemical experiments and the attempts for structural characterization of ADARs. In chapter 1, an overview of RNA editing and its consequences are described with respect to A-to-I editing mediated by ADARs, highlighting its catalytic activity, substrate selectivity, and biological consequences that are linked to various human diseases. More details on the biological role of ADAR1 in humans are included to further emphasize the importance of understanding ADAR1 biology. Chapter 2 describes the high-throughput functional screening of the 5' binding loop of ADAR1. The 5' binding loop of ADARs plays an important role in RNA recognition. Yet, its sequence is substantially different among ADARs. Therefore, this work helps us better understand the selectivity difference between ADAR1 and ADAR2. Chapter 3 is focused on the exploration of covalent crosslinking, which takes advantage of a disulfide bond formation between the Cys mutant of ADARs and thiol modified dsRNA to stabilize various ADAR-dsRNA complexes for biophysical characterization. Various novel thiol modified nucleoside analogs are utilized to optimize covalent crosslinking of ADARs and the results suggest this strategy has the potential to advance our knowledge of ADARs through structural studies. Chapter 4 describes the discovery of a second metal binding site that is unique to ADAR1 and important for its catalytic activity along with the computational modeling of the ADAR1 deaminase domain structure using this novel feature of ADAR1. These collaborative works provide more insight into the unique properties of ADAR1. In Chapter 5, the optimization of ADAR1 catalytic domain purification is described in detail that leads to several crystallization trials for biophysical characterization of the ADAR1 deaminase domain through X-ray crystallography. Moreover, results from a binding study with a duplex RNA containing an adenosine analog, 8-azanebularine, further provide an additional approach to stabilize the ADAR1-dsRNA complex for X-ray crystallography. Lastly, inhibition of ADARs activity was investigated using various small molecules, which is discussed in Chapter 6.
Author: Charles E. Samuel Publisher: Springer Science & Business Media ISBN: 3642228011 Category : Science Languages : en Pages : 244
Book Description
“The objective of this CTMI volume is to provide readers with a foundation for understanding what ADARs are and how they act to affect gene expression and function. It is becoming increasingly apparent that ADARs may possess roles not only as enzymes that deaminate adenosine to produce inosine in RNA substrates with double-stranded character, but also as proteins independent of their catalytic property. Because A-to-I editing may affect base-pairing and RNA structure, processes including translation, splicing, RNA replication, and miR and siRNA silencing may be affected. Future studies of ADARs no doubt will provide us with additional surprises and new insights into the modulation of biological processes by the ADAR family of proteins.”
Author: Charles E. Samuel Publisher: Springer ISBN: 9783642228025 Category : Science Languages : en Pages : 238
Book Description
“The objective of this CTMI volume is to provide readers with a foundation for understanding what ADARs are and how they act to affect gene expression and function. It is becoming increasingly apparent that ADARs may possess roles not only as enzymes that deaminate adenosine to produce inosine in RNA substrates with double-stranded character, but also as proteins independent of their catalytic property. Because A-to-I editing may affect base-pairing and RNA structure, processes including translation, splicing, RNA replication, and miR and siRNA silencing may be affected. Future studies of ADARs no doubt will provide us with additional surprises and new insights into the modulation of biological processes by the ADAR family of proteins.”
Author: Yuru Wang Publisher: ISBN: 9780355461879 Category : Languages : en Pages :
Book Description
Adenosine deaminases acting on RNA (ADAR) catalyze adenosine to inosine changes in double stranded RNAs, a type of post-transcriptional modification that can change the codon meaning and contribute to protein diversity in higher organisms. This modification is also known to regulate the fate of the RNA, including its expression, turnover, involvement in RNA interference and so forth. Three types of ADARs have been found in mammals, with ADAR1 and ADAR2 being catalytically active whereas ADAR3 being considered catalytically inactive. Malfunctions of ADARs have been correlated with various human diseases, including cancer. The Beal lab over the years has devoted extensive efforts in elucidating how ADARs recognize RNA substrates, and understanding the mechanism behind the RNA recognition difference between ADAR1 and ADAR2. These efforts not only advance our understanding of how these enzymes function, but also pave the way for future development of ADAR specific inhibitors of therapeutic significance. This thesis is a continuation of these efforts contributing to our understanding of how these fascinating enzymes function and providing new tools for future studies of them. Chapter 1 is an introduction of background knowledge about A-to-I RNA editing and ADAR. Chapter 2 introduced a new phenotypic reporter system that utilizes an RNA substrate efficiently processed by both ADAR1 and ADAR2 catalytic domains (ADAR-D) and a study utilizing this reporter to probe the RNA recognition by the base flipping residue in ADAR1. On the basis of this reporter system, in Chapter 3, a fluorescent reporter assay was developed to achieve high-throughput and quantitative evaluation of ADAR editing activity never achieved by other assays before, and a method called Sat-FACS-seq was introduced which provides information-rich landscape of sequence requirement across any region in ADARs. Applying this method to the 5’ binding loop of ADAR2, a novel insight into how this loop recognizes RNA was obtained. Chapter 4 detailed a study on the RNA secondary structural features that could distinguish ADAR1-D editing from ADAR2-D editing. Experimental evidence was shown, for the first time, to prove that the 5’ binding loops contribute to the site selectivity difference between ADAR1 and ADAR2, probably through differential recognition of RNA structure in the region 5’ from the editing site. Lastly, in Chapter 5, an effort to evolve the inactive ADAR3 into an active deaminase was described. Our success in turning ADAR3 into an active deaminase not only provides structural explanation of why wild-type ADAR3 is catalytically inactive, but also advances our knowledge of important residues required for proper ADAR function other than the ones traditionally appreciated. Moreover, the active ADAR3 mutant obtained was introduced with a minimal number of mutations (five), none of which was located in the RNA binding domains or on the primary RNA recognition surfaces. Thus, the mutant would be of great value for identifying the cellular binding targets of ADAR3 in vivo, which is important for understanding its biological function.
Author: Yuxuan Zheng Publisher: ISBN: 9780355872699 Category : Languages : en Pages :
Book Description
Adenosine Deaminases Acting on RNA (ADARs) are a family of enzymes that is responsible for the adenosine to inosine conversions within duplex RNA. Inosine is a commonly occurring modified nucleoside in human RNAs and it preferentially base pairs with cytidine. A proper level of inosine modification present in RNA is important for cellular functions and dysregulated adenosine to inosine conversions are related to various diseases. My studies mostly focused on human ADAR enzymes. Much of our current understanding of ADAR proteins originated from knowledge of their substrates. Therefore, developing novel methods to identify ADAR substrates will certainly advance the field. In Chapter 2 and Chapter 3, I describe two novel methods that could be used to identify new substrates for ADARs. Both of these methods are designed using nucleoside analogs. The nucleoside analog discussed in Chapter 2, 8-aza-7-deaza-7 ethynyl adenosine, could be used for RNA secondary structure probing. The structurally flexible adenosines identified through this method have a high potential to be substrates for ADARs. The nucleoside analog discussed in Chapter 3, 8-azanebularine, was used to identify ADAR substrates based on their affinity for the enzymes. Understanding the substrate recognition of ADARs is also beneficial for novel substrate identification. In Chapter 4, I discuss several interactions between the RNA substrate and the ADAR protein. These interactions were first identified in a substrate bound ADAR2 catalytic domain crystal structure. These studies highlighted some important residues for substrate binding and nearest neighbor recognition. With the help of the substrate bound ADAR structure, a new class of substrate was discovered that is discussed in Chapter 5. I showed not only that ADARs are capable of deaminating DNA/RNA hybrids, but also that ADAR systems can be used for RNA directed DNA deamination. Although future studies are needed to confirm that such reactions can occur in cells and to develop these systems to target DNA deamination in double-stranded DNA, the work described in Chapter 5 certainly expands the potential biological functions and biotechnology applications for ADARs. Lastly, the chemically modified nucleoside containing RNAs were also used in studies for other nucleic acid modifying enzymes as well, which is discussed in Chapter 6. These modifications were successfully used to illustrate catalytic mechanisms, enhance efficacy and reduce undesired interactions for several enzymes.
Author: Rena Aviva Mizrahi Publisher: ISBN: 9781303792342 Category : Languages : en Pages :
Book Description
ADARs (adenosine deaminases acting on RNA) are enzymes that catalyze the post-transcriptional deamination of adenosine to inosine in double-stranded RNA, a type of RNA editing. Inosine is recognized by the translation machinery as guanosine, so RNA editing can result in incorporation of different amino acids than those encoded in the genome. While some structural information is available for one enzyme in this family, ADAR2, there is a distinct lack of structural information regarding ADAR1. In addition, many questions exist regarding the biological function of these enzymes. In recent years new substrates for these enzymes have been identified, but their role is unknown. This dissertation describes experiments in which we work towards better understanding the mechanism and specificity of these enzymes, in the hopes of developing new tools to study A-to-I RNA editing. In the past our lab has extensively studied ADAR2, one member of this enzyme family. We have incorporated nucleoside analogues at the editing site to probe the active site, both before any structural information was available and afterwards to complement it. None of this was possible for ADAR1 until our recent characterization of a new ADAR1 substrate RNA, described in Chapter 2. Discovery and characterization of this editing site allowed us to develop an assay to probe the ADAR1 active site using nucleoside analogues. Chapter 3 details the development and use of this assay to uncover similarities and differences in how ADAR1 and ADAR2 recognize their substrate. These differences may pave the way for development of ADAR-specific inhibitors, and further use of this assay may allow us to uncover additional intriguing differences within this family of enzymes. With the abundance of new editing sites coming to light due to recent deep sequencing studies, more tools are needed to elucidate the biological consequences of these editing events. We developed substrate-specific inhibitors of editing by targeting RNA structure and sequence, described in Chapter 4. Importantly, we found that antisense oligonucleotides can bind to ADAR substrate RNAs, disrupt the native secondary structure and inhibit editing. We tested three different analogues and found that locked nucleic acid/2'-O-methyl mixmer oligonucleotides work most efficiently to inhibit editing. This will be an important new tool for the field, as labs can now use antisense oligonucleotides to inhibit editing of their RNA of choice. Finally, we developed several new assays for ADAR2 editing, for the most part based on the serotonin 2C receptor (5HT(2C)R) pre-mRNA. This work is described in Chapter 5. Similar assays have been used in the past with the GluR-B R/G site RNA, but adapting them to use the 5HT(2C)R RNA means that new sequence and secondary structure questions can now be addressed. In addition, we have used these assays to investigate how the part of ADAR2 linking the second double-stranded RNA binding domain and the catalytic domain may influence specificity and activity.
Author: Ernesto Picardi Publisher: Humana ISBN: 9781071607893 Category : Medical Languages : en Pages : 352
Book Description
This volume provides an overview about main RNA editing mechanisms, focusing on their functions in physiological as well as pathological conditions. Chapters guide readers through state- of-the art methodologies to investigate RNA editing through wet and dry approaches. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Authoritative and cutting-edge, RNA Editing: Methods and Protocols aims to ensure successful results in the further study of this vital field.
Author: Publisher: Academic Press ISBN: 0128178205 Category : Medical Languages : en Pages : 290
Book Description
Genome Plasticity in Health and Disease provides a fully up-to-date overview on genome plasticity and its role in human physiology and disease. Following an introduction to the field, a diverse range of chapters cover genomic and epigenomic analysis and the use of model organisms and genomic databases in studies. Specific molecular and biochemical mechanisms of genome plasticity are examined, including somatic variants, De Novo variants, founder variations, isolated populations dynamics, copy-number variations, mobile elements, DNA methylation, histone modifications, transcription factors, non-coding RNAs, telomere dynamics and RNA editing. Later chapters explore disease relevance for cancer, as well as cardiovascular, neuropsychiatric, inflammatory, and endocrine disease, and associated pathways for drug discovery. - Examines the role of genome plasticity across a range of disease types, from cardiovascular disease, to cancer and neuropsychiatric disorders - Adopts an interdisciplinary approach, with expert contributions across the spectrum of basic science and disease relevance to drug discovery
Author: Publisher: Academic Press ISBN: 0323853021 Category : Science Languages : en Pages : 560
Book Description
Curing Genetic Diseases through Genome Reprogramming, Volume 182 captures an historic moment in the field of gene therapy—the dawn of a new age in which the dream of curing genetic diseases has become realizable. The volume presents the most clinically advanced gene therapy and genome editing approaches for the treatment of genetic diseases in specific organs, including difficult therapeutic targets, futuristic ideas of genetic interventions, and large scale human genome repair. An initial chapter addresses the complex ethical aspects involved in the very idea of modifying the human genome. Provides a comprehensive view of gene therapy and genome editing technologies, including epigenetic editing Describes the state-of-the-art and future directions for the treatment of genetic diseases, also considering economical aspects Presents chapters that each give a thorough review of a specific disease, target organ or visionary approach, including ethical considerations
Author: Rita Sattler Publisher: Springer ISBN: 331989689X Category : Medical Languages : en Pages : 321
Book Description
It has become evident over the last years that abnormalities in RNA processing play a fundamental part in the pathogenesis of neurodegenerative diseases. Cellular viability depends on proper regulation of RNA metabolism and subsequent protein synthesis, which requires the interplay of many processes including transcription, pre--‐mRNA splicing, mRNA editing as well as mRNA stability, transport and translation. Dysfunction in any of these processes, often caused by mutations in the coding and non--‐ coding RNAs, can be very destructive to the cellular environment and consequently impair neural viability. The result of this RNA toxicity can lead to a toxic gain of function or a loss of function, depending on the nature of the mutation. For example, in repeat expansion disorders, such as the newly discovered hexanucleotide repeat expansion in theC9orf72 gene found in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), a toxic gain of function leads to the formation of RNA foci and the sequestration of RNA binding proteins (RBPs). This in return leads to a loss of function of those RBPs, which is hypothesized to play a significant part in the disease progression of ALS and FTD. Other toxicities arising from repeat expansions are the formation of RNA foci, bi--‐directional transcription and production of repeat associated non--‐ATG (RAN) translation products. This book will touch upon most of these disease mechanisms triggered by aberrant RNA metabolism and will therefore provide a broad perspective of the role of RNA processing and its dysfunction in a variety of neurodegenerative disorders, including ALS, FTD, Alzheimer’s disease, Huntington’s disease, spinal muscular atrophy, myotonic dystrophy and ataxias. The proposed authors are leading scientists in the field and are expected to not only discuss their own work, but to be inclusive of historic as well as late breaking discoveries. The compiled chapters will therefore provide a unique collection of novel studies and hypotheses aimed to describe the consequences of altered RNA processing events and its newest molecular players and pathways.
Author: SeHee Park
Author: SeHee Park
Author: Charles E. Samuel
Author: Charles E. Samuel
Author: Yuru Wang
Author: Yuxuan Zheng
Author: Rena Aviva Mizrahi
Author: Ernesto Picardi
Author: 
Author: 
Author: Rita Sattler